114 related articles for article (PubMed ID: 15466271)
1. Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria.
Benigni A; Corna D; Zoja C; Longaretti L; Gagliardini E; Perico N; Coffman TM; Remuzzi G
J Am Soc Nephrol; 2004 Oct; 15(10):2666-74. PubMed ID: 15466271
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA
Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561
[TBL] [Abstract][Full Text] [Related]
3. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
4. Developmental renin expression in mice with a defective renin-angiotensin system.
Machura K; Steppan D; Neubauer B; Alenina N; Coffman TM; Facemire CS; Hilgers KF; Eckardt KU; Wagner C; Kurtz A
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1371-80. PubMed ID: 19710239
[TBL] [Abstract][Full Text] [Related]
5. Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors.
Chen Y; Chen H; Morris M
Exp Physiol; 2005 Sep; 90(5):739-46. PubMed ID: 15944203
[TBL] [Abstract][Full Text] [Related]
6. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
Ibrahim HN; Rosenberg ME; Hostetter TH
Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
[TBL] [Abstract][Full Text] [Related]
7. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
8. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.
Kondo S; Shimizu M; Urushihara M; Tsuchiya K; Yoshizumi M; Tamaki T; Nishiyama A; Kawachi H; Shimizu F; Quinn MT; Lambeth DJ; Kagami S
J Am Soc Nephrol; 2006 Mar; 17(3):783-94. PubMed ID: 16467449
[TBL] [Abstract][Full Text] [Related]
9. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.
Yang L; Bataller R; Dulyx J; Coffman TM; Ginès P; Rippe RA; Brenner DA
J Hepatol; 2005 Aug; 43(2):317-23. PubMed ID: 15964094
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
11. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
12. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
[TBL] [Abstract][Full Text] [Related]
14. RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2.
Lin Z; Chen Y; Zhang W; Chen AF; Lin S; Morris M
Exp Physiol; 2008 May; 93(5):676-84. PubMed ID: 18310259
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of angiotensin II receptors during renal injury and compensatory hypertrophy in the rat.
Joly E; Nonclercq D; Caron N; Mertens J; Flamion B; Toubeau G; Kramp R; Bouby N
Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):241-8. PubMed ID: 15810986
[TBL] [Abstract][Full Text] [Related]
16. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
17. In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent.
Ishola DA; van der Giezen DM; Hahnel B; Goldschmeding R; Kriz W; Koomans HA; Joles JA
Nephrol Dial Transplant; 2006 Mar; 21(3):591-7. PubMed ID: 16326737
[TBL] [Abstract][Full Text] [Related]
18. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.
Tsujino T; Naito Y; Kawasaki D; Okuda S; Sakoda T; Fujioka Y; Sugaya T; Ohyanagi M
Clin Exp Hypertens; 2005; 27(2-3):159-68. PubMed ID: 15835378
[TBL] [Abstract][Full Text] [Related]
19. Targeting the genes of angiotensin receptors.
Matsusaka T; Fogo A; Ichikawa I
Semin Nephrol; 1997 Sep; 17(5):396-403. PubMed ID: 9316207
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin II on the action potential durations of atrial myocytes in hypertensive rats.
Sonoyama K; Igawa O; Miake J; Yamamoto Y; Sugihara S; Sasaki N; Shimoyama M; Hamada T; Taniguchi S; Yoshida A; Ogino K; Shigemasa C; Hoshikawa Y; Kurata Y; Shiota G; Narahashi T; Horiuchi M; Matsubara H; Ninomiya H; Hisatome I
Hypertens Res; 2005 Feb; 28(2):173-9. PubMed ID: 16025745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
